Table: Hisamitsu -6-MTH group results

Hisamitsu Pharmaceutical Co

09/10/2015 07:00

Oct 9 (Reuters)-  
             Hisamitsu Pharmaceutical Co Inc  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   6 months ended      6 months ended       Year to  
                  Aug 31, 2015        Aug 31, 2014     Feb 29, 2016  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               82.43               77.05           164.30     
                   (+7.0 pct)          (-0.4 pct)       (+4.8 pct)   
  Operating           14.51               10.36            27.40     
                   (+40.1 pct)         (-16.9 pct)      (+33.5 pct)  
  Recurring           14.62               15.57            28.50     
                   (-6.1 pct)          (-7.6 pct)       (+0.0 pct)   
  Net                  9.38                9.57            18.30     
                   (-2.1 pct)          (-30.0 pct)      (-2.6 pct)   
  EPS              109.45 yen          111.76 yen       213.62 yen   
  EPS Diluted      109.45 yen                                        
  Ann Div                               80.00 yen        80.00 yen   
  -Q2 div           40.00 yen           37.50 yen                    
  -Q4 div                               42.50 yen        40.00 yen   
   
  NOTE - Hisamitsu Pharmaceutical Co Inc is a major maker of anti-inflammatory  
 analgesic agents.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T  
  ((Tokyo Headline News Desk +813 6441 1812))